Apr 20, 2020
Immutep Quarterly Activities Report
Apr 14, 2020
Immutep Advances Cell Line Development for IMP761
Immutep TACTI-002 Data Presentation at the AACR Virtual Annual Meeting 2020
Apr 08, 2020
Immutep’s Partner, EOC Pharma, Continues to Advance Efti in Breast Cancer
Mar 24, 2020
Immutep Reports Supportive Efficacy Data from the Phase IIb AIPAC Study; Overall Survival Data Expected in Late 2020
